Shares of GlaxoSmithKline plc (ADR) (NYSE:GSK) ended Tuesday session in green amid volatile trading. The shares closed up +0.22 points or 0.50% at $43.44 with 3.26 million shares getting traded. Post opening the session at $43.89, the shares hit an intraday low of $43.23 and an intraday high of $43.92 and the price vacillated in this range throughout the day. The company has a market cap of $106.09 billion and the numbers of outstanding shares have been calculated to be 4.87 billion shares.
GlaxoSmithKline plc (ADR) (GSK) announced the publication of detailed results from a randomised phase III study (ZOE-70) of its investigational shingles vaccine, Shingrix™, showing 90% efficacy in adults aged 70 years and older that is maintained for at least four years. The results were published in the New England Journal of Medicine (NEJM).
The study, from which headline results were reported in October 2015, showed that the two-dose candidate shingles vaccine had 90% efficacy (95% confidence interval: 84-94%) compared to placebo in people over 70 years old. Vaccine efficacy was maintained across the various age groups included in the study, ranging between 90% in people aged 70-79 years (95% confidence interval: 83-94%) and 89% in those aged 80 years and above (95% confidence interval: 74-96%).
The high efficacy is in line with the results of the ZOE-50 trial, a study in people over 50 years old which was presented and published last year showing a 97% efficacy (95% confidence interval: 93-99%). A pooled analysis of data from both trials showed the vaccine demonstrated 91% efficacy against shingles (95% confidence interval: 86-95%) in adults aged 70 years and older compared to placebo. This efficacy was maintained with an 88% reduction in the risk of shingles (95% confidence interval: 73-95%) in the fourth year after vaccination.
Shares of CVS Health Corp (NYSE:CVS) ended Tuesday session in red amid volatile trading. The shares closed down -0.87 points or -1.00% at $86.22 with 6.82 million shares getting traded. Post opening the session at $87.19, the shares hit an intraday low of $86.02 and an intraday high of $87.41 and the price vacillated in this range throughout the day. The company has a market cap of $89.97 billion and the numbers of outstanding shares have been calculated to be 1.07 billion shares.
In recognition of October’s American Pharmacists Month, CVS Health (CVS) is celebrating the important role its nearly 30,000 pharmacists play in helping people on their path to better health. The company’s pharmacists are helping to change the way health care is delivered by increasing access, lowering costs and improving care quality in the company’s retail, mail service and specialty pharmacies across the country.
“Whether providing face-to-face consultations at the pharmacy counter or helping patients with complex conditions manage their specialty medications by phone, our pharmacists are truly the front line of health care,” said Larry Merlo, President and CEO, CVS Health. “Our pharmacists are not only trusted resources for patients, but are also key players in the evolution of CVS Health, delivering innovative products and services and enabling our patients and clients to manage health in more effective and affordable ways.”
Beyond simply filling prescriptions, CVS Health pharmacists are helping the company’s patients manage their health care through a number of programs and services.
As medication experts within the broader health care team, CVS Health pharmacists are helping identify potential barriers to medication adherence and offering solutions to help encourage patients to stay adherent. Pharmacists also educate patients about potential side effects and drug interactions and help identify potential gaps in care for those with complex medical conditions.
CVS Pharmacy and CVS Specialty pharmacists are working together to provide patients choice and flexibility in how they access their specialty medications and receive expert clinical support through the Specialty Connect program. The partnership gives patients the option to bring their specialty prescriptions to any CVS Pharmacy, while still receiving insurance guidance and dedicated clinical support by phone from a team of specialty pharmacy experts at CVS Specialty.
Pharmacists are providing convenient and accessible access to flu shots and other vaccinations at every CVS Pharmacy location nationwide seven days a week with no appointment needed, including evenings and weekends.
CVS pharmacists are helping patients understand their prescription insurance coverage options under Medicare Part D and the Affordable Care Act during open enrollment, which begins on October 15 and November 1, respectively.
CVS pharmacists are working to reduce prescription drug abuse through the company’s Pharmacists Teach program. This community outreach program connects pharmacists with high school health classes to share vital information about the dangers of improper drug use. CVS pharmacists have already delivered this program to more than 100,000 students across the country.